Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Post by therivercardon Sep 15, 2018 4:57pm
469 Views
Post# 28626846

A lot to comprehend on this flight

A lot to comprehend on this flightWhat seems to have been a significant orchestrated pull back and partial recovery.....
followed by an after hours US market listing annoucement,
22 trading days left before the October 17 greenlight in Canada,
a majority of  political support in the US toward legaliation, 
the strong likelihood that a partnership with at least one of big pharma/big tobacco/big food-drink is in the works,
many other geographies to consider,
and what seems to be limitless potential for medical applications....

There are potentially too many paradigm shifts currently for any technical trading algorithm to extend in relation to projected share prices. And with the success of Weed,Cronos and Tilray south of the border, should ACB investors expect to see a similar response with a minimum of $20Cdn by the end of October with a SP 2/3/4 x a year out from this that date?  

With this last announcement Aurora has been cleared for take off, time to buckle up!  GLTA

Bullboard Posts